Mexico’s Debt to Domestic Laboratories: A Growing Concern

Web Editor

December 19, 2025

a man in a suit and tie standing with his arms crossed in front of him, with a blue background, Carl

Introduction

The Mexican government’s debt to domestic laboratories remains a topic of concern. Despite ongoing negotiation efforts and partial payments for debts from 2024 and 2025, older debts remain unscheduled for payment. Moreover, a significant portion of payments has gone to foreign laboratories, leaving substantial debt with domestic ones.

The Debt Landscape

  • The IMSS-Bienestar owes between 2,000 million to 2,500 million pesos to domestic laboratories.
  • Approximately 1,000 million pesos of this debt is inherited from the Insabi.
  • The exact timeline for these payments remains unclear due to administrative disarray discovered by IMSS-Bienestar authorities.

Impact on Domestic Laboratories

Juan de Villafranca, President of the Mexican Pharmaceutical Laboratories Association (Amelaf), highlights that most payments have gone to foreign companies. Despite the significant debt, domestic laboratories continue participating in government tenders and delivering required medications.

Government’s Stance

President Claudia Sheinbaum reported that her government has paid around 15,000 million pesos in past medication debts. She emphasized the need for thorough documentation review before payments, ensuring both quantity and quality compliance.

Subsecretary’s Update

Eduardo Clark, Subsecretary of Integrated Sectoral Coordination and Medical Services at the Ministry of Health, stated that the 15,000 million pesos payment to the pharmaceutical industry reduced remaining debt to between 5,000 and 7,000 million pesos. He noted that the debt once exceeded 10,000 million pesos.

Coinciding Perspectives

Both the government and laboratories agree on ongoing debt reconciliation and recognition of overdue amounts. However, the prioritization of international companies over domestic ones raises concerns.

Banxico’s Interest Rate Decision

No Surprises: Banxico Cuts Rate

The Bank of Mexico (Banxico) reduced its reference rate by 25 basis points to 7%, as widely anticipated. The decision was made with four affirmative votes and one dissenting vote from Subgovernor Jonathan Heath.

Despite annual inflation closing at 3.80% in November, surpassing October’s 3.57%, Banxico believes inflation will reach its 3% target, with a margin of more or less one percentage point, by the third quarter of 2026.

Inflation Expectations

Private sector analysts expect convergence towards the target to occur by 2027.

Key Questions and Answers

  • Q: What is the current debt situation between the Mexican government and domestic laboratories? A: The Mexican government owes between 2,000 million to 2,500 million pesos to domestic laboratories, with approximately 1,000 million pesos inherited from the Insabi. The exact payment timeline remains unclear due to administrative disarray.
  • Q: How has the Mexican government addressed past medication debts? A: President Claudia Sheinbaum reported that her government has paid around 15,000 million pesos in past medication debts, emphasizing the need for thorough documentation review before payments.
  • Q: What is Banxico’s recent interest rate decision? A: Banxico reduced its reference rate by 25 basis points to 7%, despite annual inflation closing at 3.80% in November.
  • Q: What are private sector analysts’ expectations for inflation convergence? A: Private sector analysts expect convergence towards the target to occur by 2027.